Multicenter clinical experience with non‐invasive cell‐free DNA screening for monosomy X and related X‐chromosome variants
Prenatal Diagnosis · 2023
DOI: 10.1002/pd.6320 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Prenatal Diagnosis, 2023. Verfasst von Ivonne Bedei und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Prenatal Medicine and Fetal Therapy, Justus-Liebig University, Giessen, Germany. Hauptthemen laut MEDLINE: Turner Syndrome, Cell-Free Nucleic Acids, Down Syndrome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
We aimed to investigate how the presence of fetal anomalies and different X chromosome variants influences Cell‐free DNA (cfDNA) screening results for monosomy X.
Methods
From a multicenter retrospective survey on 673 pregnancies with prenatally suspected or confirmed Turner syndrome, we analyzed the subgroup for which prenatal cfDNA screening and karyotype results were available. A cfDNA screening result was defined as true positive (TP) when confirmatory testing showed 45,X or an X‐chromosome variant.
Results
We had cfDNA results, karyotype, and phenotype data for 55 pregnancies. cfDNA results were high risk for monosomy X in 48/55, of which 23 were TP and 25 were false positive (FP). 32/48 high‐risk cfDNA cases did not show fetal anomalies. Of these, 7 were TP. All were X‐chromosome variants. All 16 fetuses with high‐risk cfDNA result and ultrasound anomalies were TP. Of fetuses with abnormalities, those with 45,X more often had fetal hydrops/cystic hygroma, whereas those with “variant” karyotypes had different anomalies.
Conclusion
Both, 45,X or X‐chromosome variants can be detected after a high‐risk cfDNA result for monosomy X. When there are fetal anomalies, the result is more likely a TP. In the absence of fetal anomalies, it is most often an FP or X‐chromosome variant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Prenatal Medicine and Fetal Therapy, Justus-Liebig University, Giessen, Germany.
- Prenatal Medicine and Genetics München, Duesseldorf, Germany.
- Center for Prenatal Diagnosis, Mathias-Spital, Rheine, Germany.
- Center for Prenatal Medicine and Human Genetics, Hamburg, Germany.
- Center for Prenatal Medicine on Elbe Hamburg, Hamburg, Germany.
- Center for Prenatal Medicine, Mainz, Germany.
ORCID-Profile: Ivonne Bedei, Ignatia B Van den Veyver
Zitieren
APA
Bedei, I., Gehrke, T., Gloning, K. P., Meyer-Wittkopf, M., Willner, D., Krapp, M., Scharf, A., Degenhardt, J., Heling, K. S., Kozlowski, P., Trautmann, K., Jahns, K. M., Geipel, A., Baumüller, J. E., Wilhelm, L., Gottschalk, I., Schröer, A., Graf, A., Wolter, A., …, & Axt-Fliedner, R. (2023). Multicenter clinical experience with non‐invasive cell‐free DNA screening for monosomy X and related X‐chromosome variants. Prenatal Diagnosis. https://doi.org/10.1002/pd.6320
Vancouver
Bedei I, Gehrke T, Gloning KP, Meyer-Wittkopf M, Willner D, Krapp M, et al. Multicenter clinical experience with non‐invasive cell‐free DNA screening for monosomy X and related X‐chromosome variants. Prenatal Diagnosis. 2023. doi:10.1002/pd.6320
BibTeX
@article{Bedei2023,
author = {Bedei, Ivonne and Gehrke, Tascha and Gloning, Karl-Philipp and Meyer-Wittkopf, Matthias and Willner, Daria and Krapp, Martin and Scharf, Alexander and Degenhardt, Jan and Heling, Kai-Sven and Kozlowski, Peter and Trautmann, Kathrin and Jahns, Kai M and Geipel, Annegret and Baumüller, Jan-Erik and Wilhelm, Lucas and Gottschalk, Ingo and Schröer, Andreas and Graf, Alexander and Wolter, Aline and Schenk, Johanna and Weber, Axel and Van den Veyver, Ignatia B and Axt-Fliedner, Roland},
title = {Multicenter clinical experience with non‐invasive cell‐free DNA screening for monosomy X and related X‐chromosome variants},
journal = {Prenatal Diagnosis},
year = {2023},
doi = {10.1002/pd.6320}
}
EUVIMED